Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2008
10/22/2008EP1287364B1 Diagnostics and therapeutics for macular degeneration-related disorders
10/22/2008CN101289471A Process for separating total alkaloids of corydalis rhizome form Chinese medicament extracting solution of corydalis rhizome
10/22/2008CN101289442A Novel benzoimidazole derivatives useful as antiproliferative agents
10/22/2008CN101288745A Chinese medicinal composition for treating dehcets disease and preparation method thereof
10/22/2008CN101288734A Decoction for treating ear dizziness
10/22/2008CN101288708A Chinese medicinal preparation for treating ophthalmic vertigo
10/22/2008CN101288679A Dissolving and reducing generation method of nano pearl powder
10/22/2008CN101288639A Method for purifying pearl hydrolysate using hyperfiltration and nanofiltration
10/22/2008CN100427126C Chinese herbal medicine enama for treating immunological eye diseases and its prepn process
10/22/2008CN100427091C Gatiflxacin eye gels based on HPMC medium and its preparing method
10/21/2008US7439397 reacting methyl bromide and 2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-(trifluoromethyl) phenol; formation of (3R)-3-[2-hydroxy-5-(trifluoromethyl)phenyl]-N,N-diisopropyl-N-methyl-3-phenylpropan-1-aminium bromide; asthma, chronic obstructive pulmonary disorder, allergic and infectious rhinitis
10/21/2008US7439251 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
10/21/2008US7439063 Providing acute neuroprotection by contacting neuronal cells with erythropoietin or active fragment or analog thereof close to or subsequent to time of excitatory insult and contacting cells with insulin-like growth factor, thereby producing synergistic acute neuroprotective effect; Alzheimer's disease
10/21/2008CA2468847C Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
10/21/2008CA2282345C Pharmaceutical composition
10/21/2008CA2270893C N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity
10/16/2008WO2008124151A2 Use of creatine compounds for the treatment of eye disorders
10/16/2008WO2008124009A2 Treating glaucoma
10/16/2008WO2008123582A1 Tetrahydroisoquinoline compound
10/16/2008WO2008123395A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
10/16/2008US20080255246 Carotenoids as pretreatments for mammals at risk of an ischemic event; ischemic osteonecrosis, peritoneal ischemia, chronic ocular disease, macular degeneration, diabetic retinopathy
10/16/2008US20080255227 7-[(1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo[4.3.0]nonane-8-one-7-yl]heptanoic acid and a glyceride; improved stability
10/16/2008US20080255220 Therapeutic Substituted Gamma Lactams
10/16/2008US20080255191 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/16/2008US20080255176 1-methyl-3 beta -hydroxymethyl-6-methoxy-1,2,3,4,4a alpha ,5,10, 10a beta -octahydrobenzo[q]quinoline; decrease on the intraocular pressure; glaucoma and myopia; excellent tolerability, and a long duration of action
10/16/2008US20080255173 Novel Specific Caspase-10 Inhibitors
10/16/2008US20080255172 Pyrimidine derivatives
10/16/2008US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease
10/16/2008US20080255146 Macrolide compounds comprising 18,19-epoxytricosa-8,12,14-trien-11-olide derivatives; angiogenesis inhibitors; anticarcinogenic, antimetastasis, antiinflammatory, and antitumor agents; antihypoxic agents; endothelial growth factor suppressors; retinal neovascularization, diabetic retinopathy
10/16/2008US20080255141 Modulators of signal transduction mediated by certain native and/or mutant tyrosine kinases; antiproliferative, anticarcinogenic, antiallergen, and antiinflammatory agents; metabolic and neurodegenerative disorders
10/16/2008US20080255059 Regulators of the hedgehog pathway, compositions and uses related thereto
10/16/2008US20080254153 Water Dispersible Composition and Method for Preparing Same
10/16/2008US20080254140 treating vision defects of macular degeneration, atrophy of the pigmented epithelium of the retina and photoreceptors in an eye; reducing the formation of drusen in an eye of a human; isotretinoin
10/16/2008US20080254096 Using polyvinyl alcohol free biodegradable polymer matrix; reducing side effects, invasive procedures and high transient concentrations; glaucoma, proliferative vitreoretinopathy
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008CA2680838A1 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitory effect as active ingredient
10/15/2008EP1980249A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
10/15/2008EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
10/15/2008EP1383786B1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
10/15/2008EP1379207A4 Composition for freshening nostrils and sinus cavities
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1019057B1 A method of preventing or treating estrogen-dependent diseases and disorders
10/15/2008CN101284080A Shizi capsules for tonifying kidney and improving eyesight
10/15/2008CN101284048A Formulations for effectively improving hypometropia, asthenopia, cataract, eyeground pathological changes
10/15/2008CN101284030A Quality control methods of hairy holly root medicinal materials, extract or hairy holly root preparation
10/15/2008CN101284006A Medicine composition for treating eye disease
10/15/2008CN101284005A Application of indirubin for preparing medicine for preventing blood vessel from regenerating
10/15/2008CN101283994A Application of plumbagin in preparing the medicine for preventing the blood vessel from regenerating
10/15/2008CN101283807A PUFA supplements
10/15/2008CN100425592C Indole derivatives
10/15/2008CN100425241C Glaucoma-treating agent consisting of RHo kinase inhibitor and prostaglandin
10/15/2008CN100425229C Local medicine preparation containing antiinfective medicine composition and its preparing method
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435756 Preparation and diabetic use of gibberellins
10/14/2008US7435745 Methods and compositions for inhibition of angiogenesis
10/14/2008US7435744 Brain disorders; central nervous system disorders; viricides
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435729 using estrogen antagonist ; anticancer agents
10/14/2008US7435724 Degradation-resistant mononucleoside phosphate compounds
10/14/2008CA2430995C Reversible gelling system for ocular drug delivery
10/14/2008CA2387727C Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2339244C Methods of ophthalmic administration
10/14/2008CA2322380C Method of preventing the death of retinal neurons and treating ocular diseases
10/09/2008WO2008121665A1 Methods and compositions for intraocular administration to treat ocular conditions
10/09/2008WO2008121019A1 Antihistaminic and antiallergic agent and a method for the production thereof.
10/09/2008WO2008120713A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions
10/09/2008WO2008120653A1 Indoledione derivative
10/09/2008WO2008120099A1 Thieno [3, 2-e] [1, 2] thiazine derivative as inhibitor of carbonic anhydrase
10/09/2008WO2008119850A1 Topical formulation for treatment of ocular hypertension and glaucoma
10/09/2008WO2008119772A1 Amide derivatives as inhibitors of aspartyl proteases
10/09/2008WO2008119544A1 Novel use of genistein
10/09/2008WO2008103301A3 Treatment of the eye using macrophages and/or agents able to affect blood vessel morphology
10/09/2008WO2008101052A3 Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract
10/09/2008WO2008094912A3 Substituted gamma lactams as therapeutic agents
10/09/2008WO2008067127A3 Water insoluble polymer matrix for drug delivery
10/09/2008WO2008064337A3 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
10/09/2008WO2008024983A3 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions
10/09/2008WO2008021729A3 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases
10/09/2008WO2008021728A3 Treating infections and sequelae thereof with combined dissociated' glucocorticoid receptor agonists and anti-infective agents
10/09/2008WO2007100566A3 Use of dha and ara in the preparation of a composition for regulating gene expression
10/09/2008WO2006074117A3 Silver/water, silver gels and silver-based compositions; and methods for making and using the same
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249109 Pyrazinoylguanidine compounds for use as taste modulators
10/09/2008US20080249065 glycine and proline; to treat a corneal ulceration; promote corneal re-epithelialisation and rapid healing; treatment of dry eye
10/09/2008US20080248997 Modified g-protein coupled receptor for identifying modulators of taste preception; artificial sweeteners
10/09/2008US20080248996 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
10/09/2008US20080248135 Combination Therapy for Otitis with Antiseptic and pH Adjustment
10/09/2008US20080248021 Use of Hyaluronidase in Combination with Plasmin for the Induction of Posterior Vitreous Detachment
10/09/2008US20080247953 Drug screening assays; SH2 docking domains; signal sequences; immunology; cyclophilins
10/09/2008CA2682727A1 Indoledione derivative
10/09/2008CA2682375A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous activity
10/08/2008EP1977740A1 Composition comprising formoterol and a glucocorticosteroid
10/08/2008EP1976595A2 The use of memantine and brimonidine to attenuate vitreoretinal vascular endothelial growth factor (vegf) protein levels in animals
10/08/2008EP1976494A1 Adenosine a3 receptor agonists for the treatment of dry eye disorders
10/08/2008EP1732567B1 Use of a phenothiazine derivative for preventing and/or treating hearing loss
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1499360B1 Formulation comprising buprenorphine
10/08/2008EP1487469B1 Co-beadlet of dha and rosemary
10/08/2008EP1476128B1 Lipase inhibiting composition
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 531